Navigation Links
Zymes Omega Solutions Bottles and Launches the World's First Omega-3 Enhanced Water
Date:3/16/2009

OmegaChill, the world's first omega-3 enhanced water is available for immediate distribution

HASBROUCK HEIGHTS, N.J., March 16 /PRNewswire/ -- Zymes Omega Solutions, Inc., an affiliate of Zymes LLC, announces the successful bottling and launch of the world's first omega-3 enhanced water, OmegaChill (http://www.omegachill.com). This innovative new water uses Zymes' PTS technology to solubilize and stabilize fish-derived omega-3s. The resulting beverage delivers 50mg of EPA/DHA and has long-term shelf-stability at room temperature. The beverage also contains Vitamins C, E, B3, B6, B12, B5 and is naturally sweetened with Stevia with zero calories. The beverage is currently available in two flavors, Clearberry and Lemon-lime (lemon-lime contains electrolytes). OmegaChill will be on selected store shelves in the North East. Zymes Omega Solutions is seeking additional distribution partners for the enhanced waters and is licensing the technology for other food and beverage categories.

Zymes Omega Solutions uses Zymes water-solubilization technology, PTS(TM) to solubilize and stabilize omega-3s into nanomicelles with an average particle size of 25 nanometers, thus allowing for the formulation to be crystal clear in water. Zymes Omega Solutions, a leader in the solubility and stability of omega-3 fatty acids, offers formulation services and private label solutions in select categories. The technology is also available for licensing in select categories as well. Additionally, Zymes Omega Solutions has produced a dry powder formulation which is stable, water-soluble and can be used for a number of product applications.

"It is extremely gratifying to be launching the world's first omega-3 enhanced water," said Benjamin D. Mamola, Chief Executive Officer of Zymes Omega Solutions Inc. "In addition to the enhanced water, our company is developing other omega-3 enhanced products including omega-3 kids' drink pouches, ready-to-eat gelatins, granola bars, dry stick packs and high concentrate omega-3 shots. We look forward to becoming the new standard in the delivery of omega-3s for food and beverage products world-wide."

The solubilization compound, PTS, is being manufactured at scale by Albemarle, one of Zymes' manufacturing partners. Albemarle's commercial scale and quality is helping satisfy the increasing demand of PTS/Omega-3s for food and beverage applications. Zymes Omega Solutions' PTS/omega-3s is GRAS-affirmed for food and beverage applications. Zymes Omega Solutions' holds the world-wide exclusive rights to PTS/omega-3s for all food and beverages.

About Zymes Omega Solutions:

Zymes Omega Solutions Inc., a Delaware Corporation and affiliate of Zymes LLC, is a bio-science company that combines science and technology to create and enable Omega-3 fortified consumer products that promote health and wellness. Based in Hasbrouck Heights, NJ, Zymes Omega Solutions holds the world-wide exclusive rights for the use of PTS for omega-3s for food, beverage and dietary supplements. For more information, email info@zymesllc.com, or see: www.zymesomegasolutions.com and www.omegachill.com.


'/>"/>
SOURCE Zymes Omega Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Albemarle Manufactures Zymes PTS, the Lead Compound in a Breakthrough Solubilization Technology
2. Novozymes Reports Strong 2008 Results
3. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
4. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
5. Genencor Appoints New Executive Vice President - Technical Enzymes
6. Novozymes Launches Enzyme to Reduce Acrylamide in Food
7. Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
8. OmegaGenesis Announces Angiogenesis Application Collaboration
9. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
10. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
11. Martek Announces Settlement of OmegaTech Milestone Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... ... February 22, 2017 , ... NDA Partners ... MD former Acting Deputy Director in the FDA CDRH Division of Cardiovascular, Respiratory, ... joined the company as an Expert Consultant. , In Dr. Spyker’s accomplished career, ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
Breaking Biology Technology:
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):